OIRA Conclusion of EO 12866 Regulatory Review
| RIN: 0960-AF33 View EO 12866 Meetings | Received Date: 01/17/2008 |
| Title: Revised Medical Criteria for Evaluating Immune System Disorders (804F) | |
| Agency/Subagency: SSA | Stage: Final Rule |
| Concluded Action: Consistent with Change | Concluded Date: 03/05/2008 |
| Legal Deadline: None | Economically Significant: No |
| Publication Date: 03/18/2008 | Unfunded Mandates: No |
| Major: No | Related To Homeland Security: No |
| Regulatory Flexibility Analysis Required: No | Small Entities Affected: No |
| Federalism Implications: No | Affordable Care Act [Pub. L. 111-148 & 111-152]: Uncollected |
| International Impacts: Uncollected | Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]: Uncollected |
| Pandemic Response: Uncollected | |
An official website of the United States government



